Retrospective analysis of bendamustine and rituximab use in indolent and mantle cell non-Hodgkin lymphoma based on initial starting dose. [electronic resource]
Producer: 20180112Description: 1589-1597 p. digitalISSN:- 1029-2403
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bendamustine Hydrochloride -- administration & dosage
- Female
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Mantle-Cell -- diagnosis
- Male
- Middle Aged
- Neoplasm Staging
- Odds Ratio
- Proportional Hazards Models
- Retrospective Studies
- Rituximab -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.